JOSEPH III KLEIN
CIK 1206369 · last filed 2026-05-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.77M
Companies
8
Total Filings
135
Lifetime Open-Market Net
-$17.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | Director | 11,114 | $73.28 | $814.4K | -$11.41M | 42 | 2026-05-05 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Director | — | — | — | $0 | 3 | 2020-10-13 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | Director | 5,643 | — | — | -$3.38M | 21 | 2015-11-12 |
| SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Director | 17,388 | — | — | -$573.6K | 14 | 2010-07-21 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | Director | 0 | — | — | -$698.3K | 13 | 2010-06-09 |
| BMRN | Director | 35,000 | $55.95 | $1.96M | -$1.33M | 12 | 2010-03-10 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Director | 19,484 | — | — | -$36.2K | 26 | 2009-11-06 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | Director | 15,000 | — | — | -$154.7K | 4 | 2007-05-25 |
Recent Filings · Page 3 of 14
135 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-13 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2020-07-06 | IONS | Mixed | +4,000 | $0 | EDGAR |
| 2020-04-15 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-23 | IONS | Mixed | — | -$26.3K | EDGAR |
| 2019-12-18 | IONS | Mixed | — | -$29.9K | EDGAR |
| 2019-12-10 | IONS | Mixed | — | -$28.2K | EDGAR |
| 2019-12-04 | IONS | Mixed | — | -$28.6K | EDGAR |
| 2019-11-26 | IONS | Sell (S) | −812 | -$51.1K | EDGAR |
| 2019-11-21 | IONS | Sell (S) | −2,000 | -$120.0K | EDGAR |
| 2019-09-23 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.